EFPIA - NEWSLETTER

EFPIA Newsletter 22 May 2025

International Clinical Trials Day 2025

Developing a medicine takes years of research and significant investment. Clinical trials are a critical part of this journey, making it possible to bring life-changing treatments and vaccines to patients. They offer patients early access to potentially groundbreaking therapies and play a vital role in advancing medical knowledge, improving care, and saving lives.

On International Clinical Trials Day 2025, we honour the patients, researchers, scientists, and regulators across Europe who make clinical research possible.

Learn more about the importance of clinical trials here.

22 May 2025 How public-private partnerships are optimising the research ecosystem

Clinical Trials: The Innovative Health Initiative is showing the power of collaboration as a catalyst for change in...

21 May 2025 Cross-border trials: ‘Not every patient is as lucky as me’

Patient story: travelling to Germany for a clinical trial offered Savo Pilipovic access to life-saving melanoma therapy....

20 May 2025 Clinical trials: Good for patients, good for Europe

The EU Biotech Act is a unique opportunity to strengthen Europe’s clinical research ecosystem and regain global competitiveness...

Europe’s pharmaceutical industry is at a crossroads

As discussions on the General Pharmaceutical Legislation come to a head, Europe faces two choices: becoming a leader in innovative research, development and manufacturing, or losing its global standing.

Read the full POLITICO article here.

Events

03 JUN 2025

JLABS | Paths to the patient: Business models for drug discovery and development Utrecht, The Netherlands

How do you choose the right path to bring your drug discovery to patients? Join this JLABS program to discover the pros...

Learn more →

05 JUN 2025

MSCA Staff Exchanges hybrid information session Alicante, Hybrid

Join the hybrid information session on 5 June 2025 to learn more about MSCA Staff Exchanges.

Learn more →

What we are reading

'Use existing policy tools for quick health impacts' urge EU lawmakers 21 May 2025 (Euractiv)

Improving equitable access to medicines in Europe must remain a priority 21 May 2025 (The Parliament)

Making Europe more attractive for conducting clinical trials 20 May 2025 (IHI)

READI project to usher in more inclusive approach to clinical trials 14 April 2025 (IHI)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶